# Antimicrobial Resistance Patterns and Cumulative Antibiogram of Clinically Significant Bacteria From a Tertiary Hospital in Indonesia

**Authors:** Rika Bur, Muhammad Alifian Remifta Putra, Nelly Puspandari, Syukrini Bahri, Evi Yuliana, Nadya Rashita Valentina Barus, Astari Arum Sari, Talitha Dhia Fairuza

PMC · DOI: 10.1155/ijm/1397226 · International Journal of Microbiology · 2026-03-09

## TL;DR

This study presents an antibiogram from an Indonesian hospital, showing high resistance in bacteria like Klebsiella and Acinetobacter, stressing the need for better antibiotic use.

## Contribution

The paper provides a detailed, stratified cumulative antibiogram from a tertiary hospital in Indonesia, highlighting local AMR patterns.

## Key findings

- Klebsiella pneumoniae showed high multidrug resistance, with low susceptibility to third-generation cephalosporins.
- Acinetobacter baumannii was only susceptible to amikacin and trimethoprim–sulfamethoxazole in respiratory and ICU isolates.
- Escherichia coli from urine remained largely susceptible to several antibiotics, including meropenem and amikacin.

## Abstract

Antimicrobial resistance (AMR) is a critical global health threat, with disproportionately high burdens in low‐ and middle‐income countries. In Indonesia, where antimicrobial stewardship initiatives are still developing, local antibiograms are scarce yet crucial to guide evidence‐based empirical therapy.

We conducted a retrospective descriptive study of cumulative antibiogram data from YARSI Hospital, a tertiary care academic hospital in Jakarta, Indonesia, covering January–December 2024. Analysis followed Clinical and Laboratory Standards Institute (CLSI) M39‐A4 guidelines and was restricted to the first clinical isolate per species, patient, and specimen type. Susceptibility data were stratified by Gram classification, specimen source, and care setting, with semester‐wise comparisons (January–June vs. July–December).

Among 1782 clinical specimens, Klebsiella pneumoniae predominated among Gram‐negative isolates, exhibiting high multidrug resistance with ≤ 20% susceptibility to third‐generation cephalosporins, particularly in blood and ICU samples. Acinetobacter baumannii, the leading respiratory and ICU isolate, retained susceptibility only to amikacin (15%) and trimethoprim–sulfamethoxazole (25%). Escherichia coli from urine remained susceptible to ceftazidime (78%), cefepime (81%), meropenem (95%), and amikacin (93%). Gram‐positive isolates, including Staphylococcus epidermidis and Enterococcus faecalis, were largely susceptible to vancomycin and linezolid, although frequent coagulase‐negative staphylococcal bacteremia suggested challenges in aseptic technique.

The persistence of multidrug‐resistant K. pneumoniae and A. baumannii highlights the urgent need for targeted antimicrobial stewardship in Indonesian tertiary hospitals. Routine, stratified antibiogram reporting is essential to guide empirical therapy, inform policy, and curb the progression of AMR.

## Linked entities

- **Chemicals:** amikacin (PubChem CID 37768), trimethoprim–sulfamethoxazole (PubChem CID 358641), ceftazidime (PubChem CID 5481173), cefepime (PubChem CID 5479537), meropenem (PubChem CID 441130)
- **Species:** Klebsiella pneumoniae (taxon 573), Acinetobacter baumannii (taxon 470), Escherichia coli (taxon 562), Staphylococcus epidermidis (taxon 1282), Enterococcus faecalis (taxon 1351)

## Full-text entities

- **Genes:** ESBL [NCBI Gene 13906541]
- **Diseases:** deaths (MESH:D003643), infection (MESH:D007239), UTIs (MESH:D014552), bacterial infections (MESH:D001424), CoNS (MESH:D064726), infectious disease (MESH:D003141), bloodstream infection (MESH:D018805), respiratory infections (MESH:D012141), critically ill (MESH:D016638), AMR (MESH:D060467), staphylococcal bacteremia (MESH:D011023)
- **Chemicals:** ERY (-), cefotaxime (MESH:D002439), fosfomycin (MESH:D005578), penicillin (MESH:D010406), cephalosporins (MESH:D002511), macrolides (MESH:D018942), ceftriaxone (MESH:D002443), amikacin (MESH:D000583), Fluoroquinolones (MESH:D024841), linezolid (MESH:D000069349), ampicillin-sulbactam (MESH:C035444), ampicillin (MESH:D000667), AMP (MESH:D000249), imipenem (MESH:D015378), glycopeptides (MESH:D006020), trimethoprim-sulfamethoxazole (MESH:D015662), beta-Lactams (MESH:D047090), PEN (MESH:C058388), Aminoglycosides (MESH:D000617), oxazolidinones (MESH:D023303), FEP (MESH:D011138), amoxicillin-clavulanate (MESH:D019980), ciprofloxacin (MESH:D002939), clindamycin (MESH:D002981), CAZ (MESH:D002442), vancomycin (MESH:D014640), Carbapenems (MESH:D015780), meropenem (MESH:D000077731), cefepime (MESH:D000077723), levofloxacin (MESH:D064704), gentamicin (MESH:D005839), erythromycin (MESH:D004917)
- **Species:** Staphylococcus aureus (species) [taxon 1280], Homo sapiens (human, species) [taxon 9606], Staphylococcus epidermidis (species) [taxon 1282], Escherichia coli ATCC 25922 (strain) [taxon 1322345], Acinetobacter baumannii (species) [taxon 470], Enterococcus faecalis ATCC 29212 (strain) [taxon 1201292], Staphylococcus haemolyticus (species) [taxon 1283], Candida albicans (species) [taxon 5476], Candida tropicalis (species) [taxon 5482], Escherichia coli (E. coli, species) [taxon 562], Staphylococcus hominis subsp. hominis (subspecies) [taxon 145391], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Staphylococcus hominis (species) [taxon 1290], Enterococcus faecalis (species) [taxon 1351], Enterobacterales (order) [taxon 91347], Fungi (kingdom) [taxon 4751]
- **Mutations:** C-37 C
- **Cell lines:** ATCC 25923 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968586/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968586/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968586/full.md

---
Source: https://tomesphere.com/paper/PMC12968586